乳腺癌相关淋巴水肿严重程度的风险因素
这项回顾性观察研究纳入伊朗Motamed癌症研究所500例单侧乳腺癌相关淋巴水肿女性患者,评估其严重程度的风险因素。多因素分析显示放疗是晚期淋巴水肿的最强独立预测因素(OR 2.12,95%CI 1.22-3.67,p=0.007),年龄较大和切除淋巴结数量较多亦与晚期病变显著相关。
要点
- 放疗是晚期乳腺癌相关淋巴水肿的最强独立预测因素。
- 年龄较大和切除淋巴结数量较多与晚期淋巴水肿显著相关。
- 肿瘤分级、分子分型和手术类型未独立预测淋巴水肿严重程度。
核心结论
- 晚期乳腺癌相关淋巴水肿受多因素影响,尤其是放疗和淋巴结清扫范围。
研究设计与样本
- 回顾性观察研究,纳入伊朗Motamed癌症研究所500例25-75岁单侧乳腺癌相关淋巴水肿女性患者,数据收集跨越10年。
主要发现
- 晚期淋巴水肿与年龄较大(p=0.00)、切除淋巴结数量较多(p=0.04)和放疗(p=0.00)显著相关。
- 多因素分析显示放疗是晚期淋巴水肿的最强独立预测因素(OR 2.12,95%CI 1.22-3.67,p=0.007)。
- 肿瘤分级、分子分型和手术类型未独立预测淋巴水肿严重程度。
关键数值与推荐
- 淋巴水肿严重程度采用既定临床分期标准,分为早期(1期和2a期)和晚期(2b期和3期)。
- 纤维化和非凹陷性水肿亦作为淋巴水肿严重程度的指标。
临床怎么用
- 对接受放疗和淋巴结清扫范围较大的乳腺癌幸存者应加强淋巴水肿风险评估与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Breast cancer-related lymphedema (BCRL) is a debilitating condition that affects a significant proportion of breast cancer survivors, profoundly impacting their quality of life. While many studies have investigated the risk factors for BCRL occurrence, the determinants of its severity remain underexplored. METHODS: This retrospective observational study evaluated the risk factors associated with BCRL severity among patients treated at the Motamed Cancer Institute, Tehran, Iran. Female patients with unilateral BCRL aged 25-75 years were included. Data were collected over a 10-year period and analyzed for demographic, clinical, and pathological variables. Lymphedema severity was assessed using established clinical staging criteria and categorized into early-stage (stages 1 and 2a) and advanced-stage (stages 2b and 3) groups. Also, presence of fibrosis and non-pitting edema were other indicators of BCRL severity. Statistical analyses included univariate and multivariate logistic regression to identify predictors of advanced-stage BCRL. RESULTS: A total of 500 participants were analyzed, with a mean age of 41.16 ± 10.20 years and BMI of 28.72 ± 4.78 kg/m². Advanced-stage BCRL was significantly associated with older age (p = 0.00), higher number of excised lymph nodes (p = 0.04), and radiotherapy (p = 0.00). Multivariate analysis identified radiotherapy as the strongest independent predictor of advanced-stage BCRL (OR: 2.12, 95% CI: 1.22-3.67, p = 0.007). Other variables, including tumor grade, molecular subtypes, and type of surgery, did not independently predict BCRL severity. CONCLUSION: Advanced-stage BCRL is influenced by multiple factors, particularly radiotherapy and the extent of lymph node dissection. These findings underscore the importance of strategies to mitigate risk among breast cancer survivors, especially those undergoing radiotherapy. Further research is warranted to explore targeted interventions for reducing BCRL severity.
引用
- Bahanesteh A, Yarmohammadi H, Shahshenas S, et al. Risk factors for severity of breast cancer-related lymphedema. Radiat Oncol. 2025. PMID: 40394662. doi:10.1186/s13014-025-02663-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。